Pharma Surge
Pharma Surge
Intelligence Layer
๐Ÿ‡บ๐Ÿ‡ธยทJan 1, 1970Industry

Events Feb 22, 2026 Model Medicines to Present Evidence of First Direct-Acting Antiviral Potent Against HCV, HBV, HDV, and Co-Infections at CROI 2026

Publisher

M
Model Medicines

USA

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
Model Medicines
Region
USA
Scope
Industry
Published
January 1, 1970

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on modelmedicines.com

Leave the platform to read the original full article on the publisher site.

Source: Model Medicines

Scope: Industry

Open original article
Events Feb 22, 2026 Model Medicines to Present Evidence of First Direct-Acting Antiviral Potent Against HCV, HBV, HDV, and Co-Infections at CROI 2026 | Pharma Surge